PASG Passage Bio, Inc. - Common Stock
$5,08
Prix · Mai 19, 2026
Données fondamentales au Mai 12, 2026
Fourchette 52 semaines
$4–$20
7% of range
Note des analystes
HOLD
12 analysts
Objectif de cours
$11
+124% upside
P/E (TTM)
-0.8
ROE
-159.7%
Marge nette
—
PASG Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$5.08
Capitalisation Boursière
$38M
P/E (TTM)
-0.8
BPA (TTM)
$-14.35
Revenus (TTM)
—
Rendement div.
—
ROE
-159.7%
Dette/Capitaux propres
—
Fourchette 52 semaines
$4 – $20
PASG Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
—
BPA
$-14.35
2020-12-31
→
2025-12-31
Flux de trésorerie libre
—
Marges
—
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
PASG
Médiane des pairs
P/E (TTM)
-0.8
—
P/B
2.0
2.0
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
PASG
Médiane des pairs
ROA
-55.3%
-68.9%
ROE
-159.7%
-110.3%
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
PASG
Médiane des pairs
Current Ratio (Ratio de liquidité)
2.1
1.4
Quick Ratio (Ratio de liquidité réduite)
2.0
—
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
PASG
Médiane des pairs
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
PASG
Médiane des pairs
PASG Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
ACHAT
12 analystes
- Achat fort 3 25,0%
- Achat 4 33,3%
- Conserver 5 41,7%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
5 analystes · 2026-05-15
Médiane
$9.00
Moyenne
$11.40
← En dessous de tous les objectifs
$5.08
Bas
$7.00
Haut
$23.00
Objectif médian
$9.00
+77,2%
Objectif moyen
$11.40
+124,4%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
0.13%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 31 mars 2026 | $-2.16 | $-2.85 | 0.69% |
| 31 décembre 2025 | $-3.95 | $-2.62 | -1.3% |
| 30 septembre 2025 | $-2.44 | $-2.86 | 0.42% |
| 30 juin 2025 | $-2.96 | $-4.13 | 1.2% |
| 31 mars 2025 | $-5.00 | $-4.69 | -0.31% |
Comparaison avec les pairs Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| PASG | $38M | -0.8 | — | — | -159.7% | — |
| OSRH | — | — | — | — | — | — |
| QNCX | $187M | -2.0 | — | — | 700.5% | — |
| LGVN | — | -0.4 | -49.9% | -1893.6% | -247.7% | 67.0% |
| GTBP | $20M | -0.1 | — | — | -645.4% | — |
| INAB | $23M | -0.5 | — | — | -90.8% | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 12
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| R&D Expense | $23M | $40M | $61M | · | · | · | $3M | |
| SG&A Expense | $20M | $25M | $42M | $49M | $60M | $30M | $7M | |
| Operating Income | $-49M | $-70M | $-108M | $-138M | $-186M | $-113M | $-37M | |
| Interest Income | · | · | · | · | $343.0K | $670.0K | $696.0K | |
| Other Non-op | $4M | $6M | $6M | $2M | · | · | · | |
| Income Tax | $0 | $0 | · | · | · | · | · | |
| Net Income | $-46M | $-65M | $-102M | $-136M | $-185M | $-112M | $-46M | |
| EPS (Basic) | $-14.35 | $-21.04 | $-1.86 | $-2.50 | $-3.48 | $-2.91 | · | |
| EPS (Diluted) | $-14.35 | $-21.04 | $-1.86 | $-2.50 | $-3.48 | $-2.91 | · | |
| Shares (Basic) | 3,172,870 | 3,078,665 | 54,743,490 | 54,429,023 | 53,343,959 | 38,615,967 | · | |
| Shares (Diluted) | 3,172,870 | 3,078,665 | 54,743,490 | 54,429,023 | 53,343,959 | 38,615,967 | · | |
| EBITDA | $-49M | $-67M | $-105M | $-135M | $-184M | $-112M | · |
Bilan 21
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $46M | $38M | $22M | $35M | $129M | $135M | $159M | |
| Prepaid Expense | $629.0K | $838.0K | $923.0K | $926.0K | $2M | $1M | $156.0K | |
| Current Assets | $48M | $79M | $118M | $197M | $325M | $317M | $166M | |
| PP&E (Net) | $4M | $9M | $15M | $23M | $24M | $3M | $1M | |
| PP&E (Gross) | $8M | $19M | $23M | $28M | $26M | $4M | · | |
| Accum. Depreciation | $4M | $10M | $7M | $5M | $2M | $934.0K | · | |
| Other Non-current Assets | $244.0K | $463.0K | $433.0K | $4M | $6M | $8M | $12M | |
| Total Assets | $62M | $102M | $151M | $244M | $355M | $328M | $179M | |
| Accounts Payable | $1M | $742.0K | $1M | $4M | $9M | $5M | $629.0K | |
| Current Liabilities | $23M | $19M | $16M | $18M | $29M | $21M | $4M | |
| Capital Leases | $20M | $22M | $23M | $24M | · | · | · | |
| Deferred Tax | $3M | $4M | $6M | $8M | $1M | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | $41.0K | $76.0K | |
| Total Liabilities | $44M | $41M | $39M | $42M | $36M | $23M | $4M | |
| Common Stock | · | $6.0K | $5.0K | $5.0K | $5.0K | $4.0K | · | |
| Paid-in Capital | $724M | $720M | $706M | $695M | $675M | $476M | $2M | |
| Retained Earnings | $-705M | $-659M | $-594M | $-492M | $-356M | $-171M | $-59M | |
| AOCI | · | $8.0K | $-43.0K | $-966.0K | $-413.0K | $-12.0K | · | |
| Stockholders' Equity | $19M | $61M | $111M | $201M | $319M | $305M | $-56M | |
| Liabilities + Equity | $62M | $102M | $151M | $244M | $355M | $328M | $179M | |
| Shares Outstanding | 3,182,810 | 3,161,503 | 54,944,130 | 54,614,690 | 54,244,996 | 45,614,807 | 4,293,039 |
Flux de trésorerie 11
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $728.0K | $3M | $4M | $4M | $2M | $800.0K | $134.0K | |
| Stock-based Comp | $3M | $6M | $11M | $19M | $33M | $15M | $1M | |
| Other Non-cash | $10M | $8M | $9M | $-5M | $24M | $16M | · | |
| Operating Cash Flow | $-32M | $-48M | $-78M | $-118M | $-127M | $-81M | $-40M | |
| CapEx | · | $34.0K | · | · | · | · | · | |
| Investing Cash Flow | $40M | $55M | $65M | $25M | $-46M | $-172M | $-2M | |
| Stock Issued | · | · | · | · | $166M | $228M | · | |
| Net Stock Activity | · | · | · | · | $166M | $228M | · | |
| Financing Cash Flow | $23.0K | $9M | $135.0K | $-1M | $167M | $229M | $176M | |
| Net Change in Cash | $9M | $16M | $-13M | $-94M | $-6M | $-24M | $134M | |
| Taxes Paid | $0 | $0 | · | · | · | · | · |
Rentabilité 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| ROA | -55.3% | -51.2% | -51.8% | -45.5% | -54.3% | -44.3% | · | |
| ROE | -159.7% | -96.7% | -85.9% | -63.9% | -54.4% | -34.9% | · |
Liquidité et Solvabilité 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | 4.1 | 7.2 | 10.7 | 11.0 | 15.0 | · | |
| Quick Ratio | 2.0 | 1.9 | 1.3 | 1.9 | 4.4 | 6.4 | · |
Valorisation (TTM) 7
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-46M | $-65M | $-102M | $-136M | $-185M | $-112M | · | |
| Market Cap | $38M | $704M | $1.11B | $1.51B | $6.89B | $23.33B | · | |
| P/E | -0.8 | -0.5 | -10.9 | -11.0 | -36.5 | -175.7 | · | |
| P/B | 2.0 | 11.5 | 10.0 | 7.5 | 21.6 | 76.6 | · | |
| P / Tangible Book | 2.0 | 11.5 | 10.0 | 7.5 | 21.6 | 76.6 | · | |
| P / Cash Flow | -1.2 | -14.7 | -14.2 | -12.8 | -54.3 | -289.7 | · | |
| Earnings Yield | -121.6% | -185.5% | -9.2% | -9.1% | -2.7% | -0.57% | · |
Compte de résultat 10
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $4M | $5M | $4M | $6M | $8M | $10M | $9M | $10M | $12M | · | · | · | · | · | · | · | |
| SG&A Expense | $5M | $5M | $4M | $5M | $6M | $5M | $7M | $7M | $7M | $6M | $8M | $8M | $19M | $11M | $11M | $13M | |
| Operating Income | $-8M | $-14M | $-9M | $-10M | $-16M | $-14M | $-21M | $-17M | $-18M | $-18M | $-29M | $-25M | $-36M | $-28M | $-28M | $-40M | |
| Other Non-op | $688.0K | $865.0K | $906.0K | $949.0K | $1M | $2M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | · | · | · | |
| Net Income | $-8M | $-13M | $-8M | $-9M | $-15M | $-13M | $-19M | $-16M | $-17M | $-17M | $-27M | $-24M | $-34M | $-27M | $-27M | $-40M | |
| EPS (Basic) | $-2.36 | $-8.70 | $-2.44 | $-2.96 | $-4.87 | $-9.50 | $-6.15 | $-5.09 | $-0.30 | $-0.30 | $-0.49 | $-0.44 | $-0.63 | $-0.49 | $-0.49 | $-0.73 | |
| EPS (Diluted) | $-2.36 | $-8.70 | $-2.44 | $-2.96 | $-4.87 | $-9.50 | $-6.15 | $-5.09 | $-0.30 | $-0.30 | $-0.49 | $-0.44 | $-0.63 | $-0.49 | $-0.49 | $-0.73 | |
| Shares (Basic) | 3,205,866 | -65,284,764 | 3,178,710 | 3,168,933 | 3,163,914 | -59,505,994 | 3,146,582 | 3,142,537 | 56,295,540 | -109,348,536 | 54,789,410 | 54,683,817 | 54,618,799 | -108,706,991 | 54,473,945 | 54,386,318 | |
| Shares (Diluted) | 3,205,866 | -65,284,764 | 3,178,710 | 3,168,933 | 3,163,914 | -59,505,994 | 3,146,582 | 3,142,537 | 56,295,540 | -109,348,536 | 54,789,410 | 54,683,817 | 54,618,799 | -108,706,991 | 54,473,945 | 54,386,318 | |
| EBITDA | $-8M | · | $-8M | $-10M | $-16M | · | $-20M | $-17M | $-17M | · | $-28M | $-24M | $-35M | · | $-28M | $-40M |
Bilan 21
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $33M | $46M | $53M | $58M | $63M | $38M | $32M | $25M | $37M | $22M | $34M | $30M | $33M | $35M | $63M | $91M | |
| Prepaid Expense | $682.0K | $629.0K | $2M | $1M | $2M | $838.0K | $1M | $1M | $2M | $923.0K | $1M | $1M | $2M | $926.0K | $2M | $2M | |
| Current Assets | $35M | $48M | $56M | $60M | $67M | $79M | $87M | $95M | $108M | $118M | $136M | $154M | $172M | $197M | $223M | $251M | |
| PP&E (Net) | $826.0K | $4M | $5M | $5M | $6M | $9M | $10M | $13M | $14M | $15M | $16M | $20M | $22M | $23M | $23M | $24M | |
| PP&E (Gross) | $3M | $8M | $9M | $9M | $9M | $19M | $19M | $22M | $23M | $23M | $22M | $27M | $28M | $28M | $27M | $27M | |
| Accum. Depreciation | $2M | $4M | $4M | $4M | $3M | $10M | $9M | $9M | $8M | $7M | $6M | $7M | $6M | $5M | $4M | $3M | |
| Other Non-current Assets | $244.0K | $244.0K | $270.0K | $270.0K | $274.0K | $463.0K | $463.0K | $516.0K | $662.0K | $433.0K | $433.0K | $433.0K | $433.0K | $4M | $5M | $5M | |
| Total Assets | $36M | $62M | $74M | $79M | $86M | $102M | $112M | $125M | $141M | $151M | $169M | $194M | $213M | $244M | $270M | $299M | |
| Accounts Payable | $1M | $1M | $952.0K | $2M | $1M | $742.0K | $1M | $621.0K | $2M | $1M | $3M | $3M | $3M | $4M | $5M | $8M | |
| Current Liabilities | $20M | $23M | $22M | $20M | $18M | $19M | $17M | $12M | $13M | $16M | $20M | $20M | $17M | $18M | $22M | $27M | |
| Capital Leases | $5M | $20M | $21M | $21M | $21M | $22M | $22M | $22M | $23M | $23M | $23M | $23M | $24M | $24M | $24M | $24M | |
| Deferred Tax | · | $3M | · | · | · | $4M | · | · | · | $6M | · | · | · | $8M | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | · | $2M | · | · | · | |
| Total Liabilities | $25M | $44M | $43M | $41M | $39M | $41M | $39M | $35M | $36M | $39M | $43M | $43M | $43M | $42M | $46M | $51M | |
| Common Stock | · | · | · | · | $6.0K | · | $6.0K | $6.0K | $6.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | |
| Paid-in Capital | $724M | $724M | $723M | $722M | $721M | $720M | $719M | $718M | $716M | $706M | $704M | $701M | $698M | $695M | $691M | $688M | |
| Retained Earnings | $-712M | $-705M | $-692M | $-684M | $-675M | $-659M | $-647M | $-627M | $-611M | $-594M | $-578M | $-551M | $-527M | $-492M | $-465M | $-439M | |
| AOCI | · | · | · | · | · | $8.0K | $32.0K | $-67.0K | $-69.0K | $-43.0K | $-192.0K | $-340.0K | $-427.0K | $-966.0K | $-1M | $-2M | |
| Stockholders' Equity | $12M | $19M | $31M | $38M | $47M | $61M | $73M | $91M | $105M | $111M | $126M | $150M | $170M | $201M | $224M | $248M | |
| Liabilities + Equity | $36M | $62M | $74M | $79M | $86M | $102M | $112M | $125M | $141M | $151M | $169M | $194M | $213M | $244M | $270M | $299M | |
| Shares Outstanding | 3,207,810 | 3,182,810 | 3,178,710 | 3,178,710 | 62,148,274 | 3,161,503 | 61,767,286 | 61,754,786 | 61,611,796 | 54,944,130 | 54,812,972 | 54,745,680 | 54,626,690 | 54,614,690 | 54,546,596 | 54,463,235 |
Flux de trésorerie 7
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $129.0K | $127.0K | $200.0K | $200.0K | $201.0K | $675.0K | $800.0K | $800.0K | $806.0K | $743.0K | $1M | $1M | $978.0K | $996.0K | $900.0K | $900.0K | |
| Stock-based Comp | $556.0K | $609.0K | $611.0K | $923.0K | $858.0K | $1M | $1M | $2M | $2M | $2M | $3M | $4M | $3M | $3M | $3M | $6M | |
| Other Non-cash | $-6M | · | · | · | $499.0K | · | · | · | $-5M | · | · | · | $8M | · | · | · | |
| Operating Cash Flow | $-13M | $-6M | $-5M | $-6M | $-14M | $-8M | $-7M | $-13M | $-19M | $-20M | $-19M | $-17M | $-22M | $-24M | $-23M | $-26M | |
| Investing Cash Flow | $20.0K | $0 | $0 | $585.0K | $40M | $14M | $15M | $1M | $25M | $8M | $22M | $14M | $21M | $-3M | $-5M | $16M | |
| Financing Cash Flow | · | $9.0K | $0 | · | · | $47.0K | $0 | $85.0K | $9M | $46.0K | $0 | · | · | $-588.0K | $-408.0K | $-406.0K | |
| Net Change in Cash | $-13M | $-6M | $-5M | $-6M | $26M | $5M | $8M | $-12M | $15M | $-12M | $3M | $-3M | $-1M | $-28M | $-29M | $-10M |
Rentabilité 2
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -12.3% | · | -8.3% | -9.2% | -13.6% | · | -13.8% | -10.0% | -9.4% | · | -12.3% | -9.7% | -12.6% | · | -8.1% | -10.7% | |
| ROE | -25.9% | · | -14.9% | -14.6% | -20.3% | · | -19.4% | -13.3% | -12.1% | · | -15.5% | -12.0% | -15.2% | · | -9.1% | -12.2% |
Liquidité et Solvabilité 2
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | · | 2.5 | 3.0 | 3.7 | · | 5.1 | 7.7 | 8.4 | · | 6.9 | 7.7 | 10.0 | · | 10.3 | 9.2 | |
| Quick Ratio | 1.7 | · | 2.4 | 2.9 | 3.6 | · | 1.9 | 2.0 | 2.9 | · | 1.7 | 1.5 | 1.9 | · | 2.9 | 3.4 |
Valorisation (TTM) 7
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-40M | · | $-52M | $-60M | $-67M | · | $-79M | $-84M | $-102M | · | $-112M | $-124M | $-143M | · | $-156M | $-178M | |
| Market Cap | $25M | · | $26M | $25M | $439M | · | $865M | $981M | $1.66B | · | $721M | $1.03B | $1.05B | · | $1.36B | $2.57B | |
| P/E | -0.6 | · | -0.7 | -0.6 | -0.6 | · | -1.2 | -2.5 | -14.5 | · | -6.4 | -8.2 | -7.3 | · | -8.7 | -14.3 | |
| P/B | 2.1 | · | 0.8 | 0.7 | 9.4 | · | 11.9 | 10.8 | 15.9 | · | 5.7 | 6.8 | 6.1 | · | 6.1 | 10.4 | |
| P / Tangible Book | 2.1 | · | 0.8 | 0.7 | 9.4 | · | 11.9 | 10.8 | 15.9 | · | 5.7 | 6.8 | 6.1 | · | 6.1 | 10.4 | |
| P / Cash Flow | -1.9 | · | · | · | -31.7 | · | · | · | -87.9 | · | · | · | -46.6 | · | · | · | |
| Earnings Yield | -160.9% | · | -146.9% | -180.6% | -167.0% | · | -85.9% | -39.8% | -6.9% | · | -15.6% | -12.2% | -13.8% | · | -11.5% | -7.0% |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Résultat net | $-46M | $-65M | $-102M | $-136M | $-185M |
| BPA dilué | $-14.35 | $-21.04 | $-1.86 | $-2.50 | $-3.48 |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio de liquidité | 2.1 | 4.1 | 7.2 | 10.7 | 11.0 |
| Ratio de liquidité réduite | 2.0 | 1.9 | 1.3 | 1.9 | 4.4 |
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.